Key terms
About NURO
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. Its products include DPNCheck, Quell, and ADVANCE system. It also focuses on the sale of medical equipment and consumables. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Woburn, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NURO news
Apr 19
8:22am ET
NeuroMetrix Board Appointment and Equity Program Termination
Apr 19
8:02am ET
NeuroMetrix appoints Joshua Horowitz to board, terminates ATM equity facility
Mar 13
9:13am ET
NeuroMetrix reports over 2000 patients prescribed Quell Fibromyalgia
Mar 12
9:29am ET
Echo Lake calls for firing of NeuroMetrix CEO Shai Gozani
Mar 04
8:24am ET
Echo Lake calls for liquidation of NeuroMetrix
Feb 22
7:17am ET
NeuroMetrix reports Q4 EPS ($1.43) vs (73c) last year
No recent press releases are available for NURO
NURO Financials
Key terms
Ad Feedback
NURO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NURO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range